Evaluation of the role of RANK and OPG genes in Paget's disease of bone

Bone

Volumn 28, Issue 1, 2001, Pages 104-107

  Wuyts, W ^a   Van Wesenbeeck, L ^a   Morales Piga, A ^b   Ralston, S ^c   Hocking, L ^c   Vanhoenacker, F ^d   Westhovens, R ^e   Verbruggen, L ^f   Anderson, D ^g   Hughes, A ^h   Van Hul, W ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^f UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^g AMGEN INC   (United States)

^h QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Bone; Mutation analysis; Osteoprotegerin (OPG); Paget's disease of bone; Polymorphism; Receptor activator of nuclear factor B (RANK)

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; MALE; OSTEOCLAST; OSTEOLYSIS; PAGET BONE DISEASE; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

CARRIER PROTEINS; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; FAMILY HEALTH; GLYCOPROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; OSTEITIS DEFORMANS; OSTEOPROTEGERIN; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 0035142846     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(00)00411-7     Document Type: Article

References (17)

1. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
2. The epidemiology of Paget's disease of bone
3. Genetic linkage of Paget disease of the bone to chromosome 18q
4. Evidence for linkage between HLA and Paget's disease
5. Paget's disease of bone; Evidence for a susceptibility locus on chromosome 18q and for genetic heterogeneity
6. Familial Paget's disease of bone; Patterns of inheritance and frequency of linkage to chromosome 18q
7. Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis
8. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
9. Frequency and characteristics of familial aggregation of Paget's disease of bone
10. Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor
11. Paget's disease of bone
12. Familial expansile osteolysis. A new dysplasia
13. Osteoprotegerin; A novel secreted protein involved in the regulation of bone density
14. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
15. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis
16. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor
17. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL